Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 85,248 | -80,008 | -71,052 | -58,522 | -61,928 |
| Depreciation Amortization | 6,147 | 4,199 | 2,635 | 1,509 | 3,006 |
| Accounts payable and accrued liabilities | -1,684 | -4,564 | 4,321 | 1,046 | 42 |
| Other Working Capital | -110,822 | 10,612 | 15,013 | 84,057 | -2,563 |
| Other Operating Activity | 27,529 | 17,857 | 832 | 5,898 | 5,405 |
| Operating Cash Flow | $6,418 | $-51,904 | $-48,251 | $33,988 | $-56,038 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 14,827 | 2,905 | -8,460 | 49,642 |
| PPE Investments | -1,344 | -2,198 | -6,651 | -1,346 | -1,067 |
| Purchase Sale Intangibles | -691 | -1,308 | -1,091 | -497 | -568 |
| Other Investing Activity | -691 | -1,358 | -1,091 | -868 | -568 |
| Investing Cash Flow | $-2,035 | $11,271 | $-4,837 | $-10,674 | $48,007 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 10,505 | N/A | N/A |
| Debt Repayment | -2,043 | -1,487 | -1,423 | -1,920 | -1,920 |
| Common Stock Issued | 60,928 | 58,938 | 385 | 14,371 | 16,226 |
| Financing Cash Flow | $58,885 | $57,451 | $9,467 | $12,451 | $14,306 |
| Beginning Cash Position | 40,362 | 23,544 | 67,165 | 31,400 | 25,453 |
| End Cash Position | 103,630 | 40,362 | 23,544 | 67,165 | 31,728 |
| Net Cash Flow | $63,268 | $16,818 | $-43,621 | $35,765 | $6,275 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,418 | -51,904 | -48,251 | 33,988 | -56,038 |
| Capital Expenditure | -1,344 | -2,198 | -6,651 | -1,346 | -1,067 |
| Free Cash Flow | 5,074 | -54,102 | -54,902 | 32,642 | -57,105 |